Actively Recruiting
Freder1k-Study - Testing Infants for Type 1 Diabetes Risk
Led by Helmholtz Zentrum München · Updated on 2024-12-17
1000000
Participants Needed
1
Research Sites
510 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Freder1k-Study will identify infants who have a high genetic risk of type 1 diabetes.
CONDITIONS
Official Title
Freder1k-Study - Testing Infants for Type 1 Diabetes Risk
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age up to 6 weeks
- Provided written informed consent by custodial parent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut für Diabetesforschung, Helmholtz Zentrum München
Munich, Germany
Actively Recruiting
Research Team
A
Anette-Gabriele Ziegler
CONTACT
C
Christiane Winkler
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here